Worth Venture Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISRL
Isramco Inc
ISRL
|
+$12.1M |
| 2 |
Cognizant
CTSH
|
+$5.71M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$3.43M |
| 4 |
PF
Pinnacle Foods, Inc.
PF
|
+$2.98M |
| 5 |
IRBT
iRobot
IRBT
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$1.32M |
| 2 |
Insmed
INSM
|
+$950K |
| 3 |
Interactive Brokers
IBKR
|
+$774K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$754K |
| 5 |
Neurocrine Biosciences
NBIX
|
+$702K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.51% |
| 2 | Consumer Discretionary | 8.14% |
| 3 | Industrials | 5.64% |
| 4 | Communication Services | 5.16% |
| 5 | Healthcare | 3.92% |
Similar funds
Worth Venture Partners's Q4 2017 Portfolio in Review
As of Q4 2017, Worth Venture Partners held 168 positions worth $90.4M, down 22% from $115M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Worth Venture Partners deployed $39.7M of net new capital in Q4 2017, opening 38 new positions and adding to 23 existing holdings. Its largest new stake was Isramco Inc: 104,579 shares worth $45K.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 6.6% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Interactive Brokers, an estimated $774K trimmed.
- Worth Venture Partners's largest Q4 2017 buy was Isramco Inc: 104,579 shares worth $45K.
- Worth Venture Partners added most to Skechers in Q4 2017, an estimated $939K increase.
- Worth Venture Partners's biggest Q4 2017 reduction was Interactive Brokers, cutting an estimated $774K.
- Worth Venture Partners fully exited PTC Therapeutics in Q4 2017, selling an estimated $1.32M.
- Worth Venture Partners's ten largest holdings make up 41% of its $90.4M portfolio in Q4 2017.
- Worth Venture Partners opened 38 new positions and closed 62 in Q4 2017.
- Worth Venture Partners's portfolio value fell 22% quarter-over-quarter to $90.4M.
Based on Worth Venture Partners's 13F filing for Q4 2017, filed 1 Feb 2018.